TY - JOUR
T1 - Lymphoplasmapheresis in Rheumatoid Arthritis
AU - Rosenberg, Stuart A.
AU - Wallace, Daniel J.
AU - Goldfinger, Dennis
AU - Klinenberg, James R.
PY - 1982/11/11
Y1 - 1982/11/11
N2 - To the Editor: The recent report by Wallace et al. (June 10 issue)1 on the effect of lymphoplasmapheresis in rheumatoid arthritis employed a well-controlled double-blind protocol. Unfortunately, interpretation of the results was at best rather impressionistic. Simply stated, the data showed that there was no significant difference in any assessment index between the sham and real lymphoplasmapheresis groups at the end of nine treatments. In order to make it appear that real differences existed, the data had to be manipulated. For example, there is no significant difference in the Ritchie Index joint scores between the two experimental groups at. . .
AB - To the Editor: The recent report by Wallace et al. (June 10 issue)1 on the effect of lymphoplasmapheresis in rheumatoid arthritis employed a well-controlled double-blind protocol. Unfortunately, interpretation of the results was at best rather impressionistic. Simply stated, the data showed that there was no significant difference in any assessment index between the sham and real lymphoplasmapheresis groups at the end of nine treatments. In order to make it appear that real differences existed, the data had to be manipulated. For example, there is no significant difference in the Ritchie Index joint scores between the two experimental groups at. . .
UR - http://www.scopus.com/inward/record.url?scp=0020480681&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020480681&partnerID=8YFLogxK
U2 - 10.1056/NEJM198211113072013
DO - 10.1056/NEJM198211113072013
M3 - Letter
C2 - 6752709
AN - SCOPUS:0020480681
SN - 0028-4793
VL - 307
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 20
ER -